Cinctive Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Cinctive Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.13M	Buy	16,213 +5,227	+48%	+$2.51M	0.3%	101
2026 Q1	$5.4M	Buy	10,986 +1,506	+16%	+$817K	0.35%	98
2025 Q4	$5.49M	Buy	9,480 +2,542	+37%	+$1.44M	0.3%	96
2025 Q3	$3.37M	Buy	+6,938	New	+$3.23M	0.16%	195
2023 Q4	–	Sell	-16,510	Closed	-$8.36M	–	496
2023 Q3	$8.36M	Buy	+16,510	New	+$8.8M	0.41%	82
2023 Q2	–	Sell	-10,223	Closed	-$5.89M	–	508
2023 Q1	$5.89M	Buy	+10,223	New	+$5.76M	0.2%	181
2022 Q3	–	Sell	-21,316	Closed	-$11.6M	–	615
2022 Q2	$11.6M	Buy	21,316 +131	+0.6%	+$72.1K	0.49%	40
2022 Q1	$12.5M	Sell	21,185 -11,477	-35%	-$6.59M	0.47%	47
2021 Q4	$21.8M	Sell	32,662 -1,759	-5%	-$1.1M	0.96%	7
2021 Q3	$19.7M	Buy	+34,421	New	+$18.9M	0.96%	7
2020 Q2	–	Sell	-17,283	Closed	-$4.9M	–	320
2020 Q1	$4.9M	Buy	+17,283	New	+$5.45M	1.09%	19

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cinctive Capital Management's TMO Position: Q2 2026 in Review

Cinctive Capital Management increased its Thermo Fisher Scientific (TMO) stake by 48% in Q2 2026, buying an estimated $2.51M and bringing the position to 16,213 shares worth $8.13M. The position accounts for 0.3% of the portfolio, ranked #101.

Cinctive Capital Management first reported a position in TMO in Q1 2020 and has held it in 11 quarters since. The position peaked at $21.8M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Cinctive Capital Management held 16,213 shares of Thermo Fisher Scientific worth $8.13M as of Q2 2026.
Cinctive Capital Management bought 5,227 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.51M.
Thermo Fisher Scientific made up 0.3% of Cinctive Capital Management's portfolio in Q2 2026, its #101 holding.
Cinctive Capital Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 11 quarters since.
Cinctive Capital Management's Thermo Fisher Scientific position peaked at $21.8M in Q4 2021.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.